AACIW IPO Complete—$230M Raised, $10.05 Per Share in Trust
Armada Acquisition Corp. II is a newly formed SPAC that completed its Initial Public Offering on May 22, 2025, selling 23,000,000 units at $10.00 per unit (including a full 3,000,000 unit over-allotment) and a simultaneous private placement of 710,000 units, generating gross proceeds of $230,000,000 and $7,100,000, respectively. Approximately $231,150,000 of proceeds are held in a Trust Account invested primarily in U.S. Treasury bills, producing interest income of $982,945 for the period and contributing to net income of $887,146 for the three months ended June 30, 2025.
Outside the Trust Account the company had $479,526 in cash as of June 30, 2025 and incurred offering costs of $14,413,386 (including a $9,200,000 deferred underwriting fee). Class A public shares are recorded as redeemable at the Trust Account value and accretion to redemption value of $19,869,840 contributed to a reported shareholders' deficit of $(8,580,675). The company has not commenced operating revenues and must complete an initial Business Combination within the 18-month window ending November 22, 2026.
Positive
- Completed Initial Public Offering raising $230,000,000 (including full 3,000,000 unit over-allotment).
- Trust Account balance of $232,132,945 (proceeds invested in short-term U.S. Treasuries), supporting redemption liquidity for public shares.
- Interest income of $982,945 generated from Trust Account investments, producing net income of $887,146 for the quarter.
Negative
- Minimal operating cash outside the Trust Account: only $479,526 available as of June 30, 2025.
- High offering and underwriting costs totalling $14,413,386, including a $9,200,000 deferred underwriting fee payable upon a business combination.
- Material accretion to redemption value of $19,869,840 contributed to a reported shareholders' deficit of $(8,580,675).
- 18-month completion deadline to close an initial Business Combination (deadline: November 22, 2026), after which liquidation and redemption mechanics apply.
Insights
TL;DR: Successful IPO secured large trust funding, generating interest income, but operating liquidity outside the trust is limited and offering costs are sizable.
Armada II executed a $230.0 million IPO with the full over-allotment exercised and placed $231.15 million in a Trust Account invested in short-term U.S. Treasuries, yielding $982,945 of interest for the period. That interest produced a reported net income of $887,146 for the quarter. However, cash available outside the Trust Account was only $479,526 at June 30, 2025, while offering and underwriting expenses totaled $14.41 million (including a $9.20 million deferred underwriting fee). The company also recorded $19.87 million of accretion of redeemable shares to redemption value that materially affected shareholders' deficit. The financing and trust position are strong for completing a business combination, but limited operating liquidity and high upfront costs are important near-term considerations for transaction execution.
TL;DR: Founder share allocations, private placement interests and deferred fees are disclosed; governance and dilution mechanics are standard but should be monitored.
The Sponsor holds 7,880,000 Class B founder shares and purchased private placement units; interests allocated to non-managing members (2,400,000 founder-share interests) were valued at $4,621,895 and treated as offering costs. Public and private warrants were issued (11,500,000 public warrants; 355,000 private placement warrants) and classified as equity at issuance. The filing documents registration rights, warrant exercise mechanics, redemption rights of public shares and deferred underwriting commissions payable upon a successful business combination. These provisions and founder allocations follow typical SPAC structures, but they introduce dilution pathways and fee obligations that investors should review in deal documents and post-combination governance arrangements.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-half of one Redeemable Warrant |
||||
| ☐ | Large accelerated filer | ☐ | Accelerated filer | |||
| ☒ | Non-accelerated filer |
Smaller reporting company | ||||
| Emerging growth company | ||||||
ARMADA ACQUISITION CORP. II
Quarterly Report on Form 10-Q
Table of Contents
| PART I. FINANCIAL INFORMATION |
| |||||
| Item 1. | Financial Statements |
1 | ||||
| Unaudited Condensed Balance Sheet as of June 30, 2025 |
1 | |||||
| Unaudited Condensed Statements of Operations for the Three Months ended June 30, 2025 and for the period from October 3, 2024 (Inception) through June 30, 2025 |
2 | |||||
| Unaudited Condensed Statement Shareholders’ Deficit for the period from October 3, 2024 (Inception) through June 30, 2025 |
3 | |||||
| Unaudited Condensed Statement of Cash Flows for the period from October 3, 2024 (Inception) through June 30, 2025 |
4 | |||||
| Notes to Unaudited Condensed Financial Statements |
5 | |||||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
15 | ||||
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
18 | ||||
| Item 4. | Controls and Procedures |
18 | ||||
| PART II. OTHER INFORMATION | ||||||
| Item 1. | Legal Proceedings |
19 | ||||
| Item 1A. | Risk Factors |
19 | ||||
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
19 | ||||
| Item 3. | Defaults Upon Senior Securities |
19 | ||||
| Item 4. | Mine Safety Disclosures |
19 | ||||
| Item 5. | Other Information |
19 | ||||
| Item 6. | Exhibits |
20 | ||||
| SIGNATURES | 21 | |||||
i
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.
ii
| ASSETS |
||||
| Current assets |
||||
| Cash |
$ | |||
| Prepaid expenses |
||||
| Prepaid insurance |
||||
| |
|
|||
| Total current assets |
||||
| Prepaid insurance – long-term |
||||
| Cash and marketable securities held in Trust Account |
||||
| |
|
|||
| TOTAL ASSETS |
$ |
|||
| |
|
|||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
||||
| Current Liabilities |
||||
| Accrued offering costs |
$ | |||
| Accrued expenses |
||||
| Advances from related party |
||||
| |
|
|||
| Total current liabilities |
||||
| Deferred underwriting fee payable |
||||
| |
|
|||
| TOTAL LIABILITIES |
||||
| |
|
|||
| Commitments and Contingencies |
||||
| Class A ordinary shares subject to possible redemption, |
||||
| Shareholders’ Deficit |
||||
| Preference shares, $ |
||||
| Class A ordinary shares, $ |
||||
| Class B ordinary shares, $ |
||||
| Additional paid-in capital |
||||
| Accumulated deficit |
( |
) | ||
| |
|
|||
| Total Shareholders’ Deficit |
( |
) | ||
| |
|
|||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
$ |
|||
| |
|
For the Three Months Ended June 30, 2025 |
For the Period from October 3, 2024 (Inception) Through June 30, 2025 |
|||||||
| General and administrative costs |
$ | $ | ||||||
| |
|
|
|
|||||
| Loss from operations |
( |
) |
( |
) | ||||
| Other income: |
||||||||
| Interest earned on cash and marketable securities held in Trust Account |
||||||||
| |
|
|
|
|||||
| Other income, net |
||||||||
| |
|
|
|
|||||
| Net income |
$ |
$ |
||||||
| |
|
|
|
|||||
| Basic weighted average shares outstanding, Class A ordinary shares subject to redemption |
||||||||
| |
|
|
|
|||||
| Basic net income per ordinary share, Class A ordinary shares subject to redemption |
$ |
$ |
||||||
| |
|
|
|
|||||
| Diluted weighted average shares outstanding, Class A ordinary shares subject to redemption |
||||||||
| |
|
|
|
|||||
| Diluted net income per ordinary share, Class A ordinary shares subject to redemption |
$ |
$ |
||||||
| |
|
|
|
|||||
| Basic weighted average shares outstanding, Class A & Class B ordinary shares not subject to redemption |
||||||||
| |
|
|
|
|||||
| Basic net income per ordinary share, Class A & Class B ordinary shares not subject to redemption |
$ |
$ |
||||||
| |
|
|
|
|||||
| Diluted weighted average shares outstanding, Class A & Class B ordinary shares not subject to redemption |
||||||||
| |
|
|
|
|||||
| Diluted net income per ordinary share, Class A & Class B ordinary shares not subject to redemption |
$ |
$ |
||||||
| |
|
|
|
|||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance – October 3, 2024 (Inception) |
$ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||
Issuance of Class B ordinary shares |
— | — | — | |||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | $ | ( |
) | ||||||||||||||||||
Balance – December 31, 2024 |
— |
— |
( |
) |
( |
) | ||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance – March 31, 2025 |
— |
$ |
— |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||
Accretion of Class A ordinary shares to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Capital contribution made by Sponsor related to the interests in founders shares allocated to non-managing members |
— | — | — | — | — | |||||||||||||||||||||||
Cost of raising capital related to interests in founders shares allocated to non-managing members |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Sale of Private Placement Units |
— | — | — | |||||||||||||||||||||||||
Fair Value of Public Warrants at issuance |
— | — | — | — | — | |||||||||||||||||||||||
Allocated value of transaction costs to Class A shares |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance – June 30, 2025 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Cash Flows from Operating Activities: |
||||
| Net income |
$ | |||
| Adjustments to reconcile net income to net cash used in operating activities: |
||||
| Payment of formation costs through promissory note |
||||
| Payment of operating costs through promissory note |
||||
| Payment of operating costs through issuance of Class B ordinary shares |
||||
| Payment of operating costs through advances from related party |
||||
| Interest earned on cash and marketable securities held in Trust Account |
( |
) | ||
| Adjustment to accrued offering costs |
( |
) | ||
| Changes in operating assets and liabilities: |
||||
| Prepaid expenses |
||||
| Prepaid insurance |
( |
) | ||
| Accrued expenses |
||||
| |
|
|||
| Net cash used in operating activities |
( |
) | ||
| |
|
|||
| Cash Flows from Investing Activities: |
||||
| Investment of cash in Trust Account |
( |
) | ||
| |
|
|||
| Net cash used in investing activities |
( |
) | ||
| |
|
|||
| Cash Flows from Financing Activities: |
||||
| Proceeds from sale of Units, net of underwriting discounts paid |
||||
| Proceeds from sale of Private Placements Warrants |
||||
| Proceeds from promissory note - related party |
||||
| Repayment of promissory note - related party |
( |
) | ||
| Payment of offering costs |
( |
) | ||
| |
|
|||
| Net cash provided by financing activities |
||||
| |
|
|||
| Net Change in Cash |
||||
| Cash – Beginning of period |
||||
| |
|
|||
| Cash – End of period |
$ |
|||
| |
|
|||
| Non-Cash investing and financing activities: |
||||
| Offering costs included in accrued offering costs |
$ | |||
| |
|
|||
| Deferred offering costs paid through promissory note – related party |
$ | |||
| |
|
|||
| Accretion of Class A ordinary shares to redemption value |
$ | |||
| |
|
|||
| Deferred underwriting fee payable |
$ | |||
| |
|
|||
| Deferred offering costs applied to prepaid expen s es |
$ | |||
| |
|
| Gross proceeds |
$ | |||
| Less: |
||||
| Proceeds allocated to Public Warrants |
( |
) | ||
| Class A ordinary shares issuance cost |
( |
) | ||
| Accretion of carrying value to redemption value |
||||
| |
|
|||
| Class A Ordinary Shares subject to possible redemption, June 30, 2025 |
$ | |||
| |
|
For the Three Months Ended June 30, 2025 |
For the period from October 3, 2024 (inception) through June 30, 2025 |
|||||||||||||||
Class A - Redeemable |
Class A & B - Non-redeemable |
Class A - Redeemable |
Class A & B - Non-redeemable |
|||||||||||||
Basic net income per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic weighted average shares outstanding |
||||||||||||||||
Basic net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
For the Three Months Ended June 30, 2025 |
For the period from October 3, 2024 (inception) through June 30, 2025 |
|||||||||||||||
Redeemable |
Non-redeemable |
Redeemable |
Non-redeemable |
|||||||||||||
Class A |
Class A & B |
Class A |
Class A & B |
|||||||||||||
Diluted net income per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Diluted weighted average shares outstanding |
||||||||||||||||
Diluted net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
| • | in whole and not in part; |
| • | at a price of $ |
| • | upon a minimum of “30-day redemption period”); and |
| • | if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $ |
June 30, 2025 |
||||
Cash |
$ | |||
Cash and marketable securities held in Trust Account |
$ | |||
For the Three Months Ended June 30, 2025 |
For period from October 3, 2024 (Inception) through June 30, 2025 |
|||||||
General administrative costs |
$ | $ | ||||||
Interest earned on cash and marketable securities held in Trust Account |
$ | |||||||
| • | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| • | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| • | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Level |
June 30, 2025 |
|||||||
Assets: |
||||||||
Cash and marketable securities held in Trust Account |
1 | $ | ||||||
May 22, 2025 |
||||
Volatility |
% | |||
Risk free rate |
% | |||
Stock price |
$ | |||
Weighted term (Yrs) |
||||
May 22, 2025 |
||||
Volatility |
% | |||
Risk free rate |
% | |||
Stock price |
$ |
|||
Weighted term (Yrs) |
||||
No. |
Description of Exhibit | |
| 3.1 | Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025) | |
| 4.1 | Warrant Agreement, dated May 20, 2025, between the Company and Continental Stock Transfer and Trust Company (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025) | |
| 10.1 | Private Placement Unit Subscription Agreement, dated May 20, 2025, between the Company and Armada Sponsor II LLC (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025). | |
| 10.2 | Private Placement Unit Subscription Agreement, dated May 20, 2025, between the Company and Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025). | |
| 10.3 | Private Placement Unit Subscription Agreement, dated May 20, 2025, between the Company and Northland Securities, Inc. (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025) | |
| 10.4 | Investment Management Trust Agreement, dated May 20, 2025, between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025). | |
| 10.5 | Registration Rights Agreement, dated May 20, 2025, among the Company, the Sponsor and the other Holders (as defined therein) signatory thereto (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025) | |
| 10.6 | Administrative Services Agreement, dated May 20, 2025, between the Company and the Sponsor (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025). | |
| 10.7 | Letter Agreement, dated May 20, 2025, among the Company, the Sponsor and each of the initial shareholders, directors and officers of the Company (incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025). | |
| 10.8 | Form of Indemnity Agreement, May 20, 2025, between the Company and each of the officers and directors of the Company (incorporated by reference to Exhibit 10.9 to the Company’s Current Report on Form 8-K filed with the SEC on May 28, 2025). | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS* | XBRL Instance Document | |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.SCH* | XBRL Taxonomy Extension Schema Document | |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | XBRL Taxonomy Extension Labels Linkbase Document | |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). | |
| * | Filed herewith. |
| ** | Furnished herewith. |
ARMADA ACQUISITION CORP. II | ||||||
| Date: August 11, 2025 | By: | /s/ Stephen P. Herbert | ||||
| Name: | Stephen P. Herbert | |||||
| Title: | Chief Executive Officer | |||||
| (Principal Executive Officer) | ||||||
| Date: August 11, 2025 | By: | /s/ Douglas M. Lurio | ||||
| Name: | Douglas M. Lurio | |||||
| Title: | President | |||||
| (Principal Accounting and Financial Officer) | ||||||